Show simple item record

dc.contributor.authorYucel, Cigdem
dc.contributor.authorAktas, Yesim
dc.contributor.authorDegim, Zelihagul
dc.contributor.authorYilmaz, Sukran
dc.contributor.authorArsoy, Taibe
dc.contributor.authorAltintas, Levent
dc.contributor.authorSozmen, Mahmut
dc.date.accessioned2020-06-21T13:06:07Z
dc.date.available2020-06-21T13:06:07Z
dc.date.issued2018
dc.identifier.issn0001-6837
dc.identifier.issn2353-5288
dc.identifier.urihttps://doi.org/10.32383/appdr/87017
dc.identifier.urihttps://hdl.handle.net/20.500.12712/11318
dc.descriptionALTINTAS, Levent/0000-0002-5148-723Xen_US
dc.descriptionWOS: 000467325500014en_US
dc.description.abstractThe present study, aims to investigate and compare the effect of insulin and embryonic stem cells (ESC) loaded nanoparticle formulations (NPs) on pancreatic-beta-TC-cell regeneration. Characterization studies of NPs were performed. Permeability of insulin and the effect of ESC on pancreatic beta cells were investigated. Insulin or glucose levels were determined and histologic investigations were also performed. ESC encapsulation efficiency was calculated by western blot analysis. The particle sizes of insulin and ESC-loaded-NPs were determined as 0.665 +/- 0.202 mu m and 0.650 +/- 0.310 mu m. The mean zeta potentials of insulin and ESC-loaded-NPs nanoparticles were found as 6.88 +/- 0.729 mV, 5.13 +/- 0.631 mV. The polydispersity index of insulin and ESC nanoparticles were 0.660 +/- 0.175, 0.620 +/- 0.205 respectively. Encapsulation efficiency of insulin and ESC-loaded-NPs were found to be 50 +/- 1.53% and 51%. Insulin release from nanoparticles was found to be 72.8% over 48h. Glucose concentrations were decreased to 201 and 202.7 mg/dL from 250 mg/dL in streptozocin (STZ) induced diabetic mice group after insulin and ESC-loaded-NPs administration. Insulin and ESC-loaded-NPs improved the blood insulin levels in all experimental groups. These NPs may be used for repairing of pancreatic cells. Healing or some degree of regeneration was observed when insulin and ESC-loaded-NPs were administered to mice. ESC-loaded-NPs can be a potential source for cell replacement therapy in the treatment of diabetes.en_US
dc.description.sponsorshipScientific and Technological Research Council of Turkey (TUBYTAK)Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK) [112S405]en_US
dc.description.sponsorshipThis work was carried out at the Faculty of Pharmacy of Gazi University as a PhD thesis and supported by the Scientific and Technological Research Council of Turkey (TUBYTAK, No. 112S405).en_US
dc.language.isoengen_US
dc.publisherPolskie Towarzystwo Farmaceutyczneen_US
dc.relation.isversionof10.32383/appdr/87017en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectembryonic stem cellen_US
dc.subjectinsulinen_US
dc.subjectPLGA nanoparticlesen_US
dc.subjectdiabetesen_US
dc.subjectpancreatic beta TC cellen_US
dc.titleEffects of Insulin and Embryonic Stem Cells Loaded Plga Nanoparticles on Pancreatic Beta Tc Cellsen_US
dc.typearticleen_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume75en_US
dc.identifier.issue6en_US
dc.identifier.startpage1377en_US
dc.identifier.endpage1389en_US
dc.relation.journalActa Poloniae Pharmaceuticaen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record